Stempoint Capital as of June 30, 2024
Portfolio Holdings for Stempoint Capital
Stempoint Capital holds 42 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Syndax Pharmaceuticals (SNDX) | 8.8 | $29M | 1.4M | 20.53 | |
| Roivant Sciences SHS (ROIV) | 8.7 | $29M | 2.7M | 10.57 | |
| Immunovant (IMVT) | 8.1 | $27M | 1.0M | 26.40 | |
| Crinetics Pharmaceuticals In (CRNX) | 7.5 | $25M | 551k | 44.79 | |
| Merus N V (MRUS) | 5.2 | $17M | 289k | 59.17 | |
| Arcellx Common Stock (ACLX) | 4.7 | $16M | 281k | 55.19 | |
| Amicus Therapeutics (FOLD) | 4.5 | $15M | 1.5M | 9.92 | |
| Immunocore Hldgs Ads (IMCR) | 3.5 | $12M | 339k | 33.89 | |
| Applied Therapeutics (APLT) | 3.1 | $10M | 2.2M | 4.67 | |
| Merck & Co (MRK) | 3.1 | $10M | 82k | 124.57 | |
| GSK Sponsored Adr (GSK) | 2.9 | $9.5M | 246k | 38.50 | |
| Autolus Therapeutics Spon Ads (AUTL) | 2.8 | $9.3M | 2.7M | 3.48 | |
| Cabaletta Bio (CABA) | 2.7 | $8.8M | 1.2M | 7.48 | |
| Kalvista Pharmaceuticals (KALV) | 2.6 | $8.7M | 737k | 11.78 | |
| Biohaven (BHVN) | 2.4 | $8.1M | 233k | 34.71 | |
| Immatics SHS (IMTX) | 1.8 | $5.8M | 502k | 11.62 | |
| Denali Therapeutics (DNLI) | 1.8 | $5.8M | 251k | 23.22 | |
| Insmed Com Par $.01 (INSM) | 1.8 | $5.8M | 87k | 67.00 | |
| Celldex Therapeutics Com New (CLDX) | 1.6 | $5.3M | 145k | 37.01 | |
| Larimar Therapeutics (LRMR) | 1.5 | $5.1M | 704k | 7.25 | |
| Tscan Therapeutics (TCRX) | 1.5 | $4.9M | 845k | 5.85 | |
| Edgewise Therapeutics (EWTX) | 1.5 | $4.9M | 271k | 18.01 | |
| Vistagen Therapeutics Ord (VTGN) | 1.4 | $4.7M | 1.8M | 2.53 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 1.4 | $4.6M | 102k | 45.25 | |
| Fulcrum Therapeutics (FULC) | 1.3 | $4.3M | 697k | 6.20 | |
| Nurix Therapeutics (NRIX) | 1.3 | $4.2M | 203k | 20.87 | |
| Pyxis Oncology Common Stock (PYXS) | 1.2 | $4.0M | 1.2M | 3.31 | |
| Janux Therapeutics (JANX) | 1.2 | $3.9M | 93k | 41.89 | |
| Ideaya Biosciences (IDYA) | 1.1 | $3.6M | 102k | 35.11 | |
| Spyre Therapeutics Com New (SYRE) | 1.1 | $3.5M | 151k | 23.51 | |
| Perspective Therapeutics Com New | 1.0 | $3.4M | 344k | 9.97 | |
| Jasper Therapeutics Com New (JSPR) | 1.0 | $3.3M | 144k | 22.70 | |
| Black Diamond Therapeutics (BDTX) | 0.9 | $3.1M | 674k | 4.66 | |
| Vigil Neuroscience (VIGL) | 0.9 | $3.0M | 744k | 4.00 | |
| Neurogene (NGNE) | 0.9 | $2.9M | 79k | 36.39 | |
| Silence Therapeutics Ads (SLN) | 0.7 | $2.4M | 125k | 19.00 | |
| Protara Therapeutics Com Stk (TARA) | 0.6 | $2.0M | 984k | 2.08 | |
| Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 0.6 | $2.0M | 200k | 10.22 | |
| Surrozen Com New (SRZN) | 0.5 | $1.6M | 144k | 10.95 | |
| Perceptive Cap Solutions Cor Cl A Ord Shs | 0.5 | $1.5M | 150k | 10.06 | |
| Praxis Precision Medicines I Com New (PRAX) | 0.4 | $1.2M | 29k | 41.36 | |
| Arcutis Biotherapeutics Call Option (ARQT) | 0.3 | $1.0M | 1.5M | 0.70 |
